John Pena
- Cancer Research top 1%
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 5
- Molecular Biology top 5%
- RNA modifications and cancer 3
- RNA Interference and Gene Delivery 3
- Connexins and lens biology 2
- Developmental Neuroscience top 10%
-
- Advanced Glycation End Products research 2
-
- Neuropeptides and Animal Physiology 2
-
- Nanoplatforms for cancer theranostics 2
- Co-authors
- Thomas TuschlSara H. RouhanifardAleksandra MihailovićMarkus HafnerJan KrützfeldtKallanthottathil G. RajeevSatoru KuwajimaRavi Braich
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
John Pena
15 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 1.1k
- Molecular Biology 1.4k
- Developmental Neuroscience 49
- Aging 16
- Applied Microbiology and Biotechnology 18
Countries citing papers authored by John Pena
This map shows the geographic impact of John Pena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Pena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Pena more than expected).
Fields of papers citing papers by John Pena
This network shows the impact of papers produced by John Pena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Pena. The network helps show where John Pena may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Pena, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 17 | |
| 2 | 2012 | 92 | |
| 3 | 2012 | 5 | |
| 4 | 2011 | 256 | |
| 5 | 2010 | 118 | |
| 6 | 2009 | 425 | |
| 7 | 2009 | 244 | |
| 8 | 2007 | 362 | |
| 9 | 2006 | 22 | |
| 10 | 2006 | 1 | |
| 11 | 2004 | 63 | |
| 12 | 2003 | 64 | |
| 13 | Generation of two non-transfected human lens epithelial cell lines | 1999 | 1 |
| 14 | 1999 | 37 | |
| 15 | Effect of a new synthetic C-nucleoside (EDTO) on cell proliferation. | 1984 | 1 |
About John Pena
John Pena is a scholar working on Cancer Research, Clinical Biochemistry and Physiology, having authored 15 papers that have together received 1.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (3 papers), RNA Interference and Gene Delivery (3 papers), Connexins and lens biology (2 papers), Advanced Glycation End Products research (2 papers), Neuropeptides and Animal Physiology (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.4k citations) and Developmental Neuroscience (49 citations). John Pena has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Thomas Tuschl, Sara H. Rouhanifard, Aleksandra Mihailović, Markus Hafner, Jan Krützfeldt, Kallanthottathil G. Rajeev, Satoru Kuwajima, Ravi Braich, Markus Stoffel and Muthiah Manoharan. Their work appears in journals such as Nature Methods, Experimental Eye Research, Methods, Genes & Development and RNA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.